tiprankstipranks
Trending News
More News >
Solid Biosciences (SLDB)
NASDAQ:SLDB
US Market

Solid Biosciences (SLDB) Income Statement

Compare
1,276 Followers

Solid Biosciences Income Statement

Last quarter (Q4 2024), Solid Biosciences's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Solid Biosciences's net income was $-42.60M. See Solid Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 8.09M$ 13.62M$ 0.00
Gross Profit
$ 0.00$ -76.56M$ 5.69M$ -45.12M$ -3.92M
Operating Expenses
$ 129.73M$ 104.31M$ 107.37M$ 85.87M$ 86.46M
Depreciation and Amortization
$ 0.00$ 2.58M$ 2.41M$ 2.96M$ 3.92M
EBITDA
$ -129.73M$ -93.43M$ -96.87M$ -69.29M$ -84.37M
Operating Income
$ -129.73M$ -104.31M$ -106.45M$ -72.25M$ -88.41M
Other Income/Expenses
$ 5.03M$ 8.30M$ 20.47M$ 66.00K$ -1.83M
Pretax Income
$ -124.70M$ -96.02M$ -85.98M$ -72.19M$ -88.29M
Net Income
$ -124.70M$ -96.02M$ -65.51M$ -72.12M$ -90.12M
Per Share Metrics
Basic EPS
$ -3.06$ -4.83$ -7.70$ -10.13$ -26.03
Diluted EPS
$ -3.06$ -4.83$ -7.70$ -10.13$ -26.03
Weighted Average Shares Outstanding
40.82M 19.88M 8.51M 7.12M 3.46M
Weighted Average Shares Outstanding (Diluted)
40.82M 19.88M 8.51M 7.12M 3.46M
Currency in USD

Solid Biosciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis